ClinicalTrials.gov
public full text
Public Domain
A Study of GlcNAc on Tear Production in NGLY1-CDDG
In patients with NGLY1-CDDG, the disorder can lead to eye damage due to not being able to produce enough tears. This study is being done to see if the dietary supplement, GlcNAc, improves tear production in patients with NGLY1-CDDG.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Phase II Study of GC101 in NSCLC#853695
- Collaborative Initial Glaucoma Treatment Study (CIGTS)#435798
- The Effect of Osteopathic Manipulative Techniques on Human Tear Composition#915819
- Effect of Soluble Corn Fiber Supplementation for 1 Year on Bone Metabolism in Adolescents#850586
- Glycemic Response in Persons with Type 2 Diabetes#1113990
Record · ID 851143
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive